Advanced Proteome Therapeutics Corporation (APTCF) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Burnaby, BC, 캐나다. 현재 CEO는 Benjamin Krantz.
APTCF 을(를) 보유 IPO 날짜 2009-07-10, 에 상장 Other OTC, 시가총액 $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
